BioSpace News Archive

Drug Development

Ultragenyx Announces Completion of Patient Dosing in First Cohort of Phase I/II Clinical Study of DTX301 Gene Therapy in Ornithine Transcarbamylase (OTC) Deficiency

Initial data from this first cohort of three patients is expected in early 2018.

November 16, 2017
·
4 min read
Drug Development

Spring Bank Pharmaceuticals Announces Positive Top-Line Results from the Second Cohort of Part A of the Phase II ACHIEVE Trial

All patients in this cohort have transitioned to tenofovir disoproxil fumarate300mg daily for an additional 12 weeks.

November 16, 2017
·
10 min read
Drug Development

Titan Medical Reports First Use of Sport Surgical System at Columbia University Medical Center

The demonstration is the first step of the preclinical feasibility and validation studies with the SPORT system completed at this world-renowned academic medical center, one of Titan’s two Centers of Excellence in the U.S.

November 16, 2017
·
6 min read
InDex Pharma Announces Nomination Committee and Financial Reporting Dates for 2018

InDex Pharma today announced the composition of the Nomination Committee for the 2018 Annual General Meeting, which will be held on Thursday May 24, 2018.

November 16, 2017
·
2 min read
Tigenix Announces Approval of Trade Name for Lead Development Candidate Cx601 in Europe

The trade name Alofisel, a registered trademark owned by TiGenix, will be used from now onwards.

November 16, 2017
·
5 min read
Pharm Country

MTPA Announces 1,000 People With ALS Have Received FDA-Approved Treatment Option in First Three Months Available

MTPA today announced that more than 1,000 people with ALS have been treated with RADICAVA (edaravone) since it became available in the U.S. in August as the first FDA-approved treatment option for the disease in more than 20 years.

November 16, 2017
·
7 min read
Pharm Country

Achillion Announces Pricing of Secondary Offering Of Common Stock

The offering is expected to close on November 20, 2017, subject to the satisfaction of customary closing conditions.

November 16, 2017
·
3 min read
Business

EDAP TMS Reports Third Quarter 2017 Results

EDAP’s HIFU patient treatment revenues grew 29% compared to third quarter 2016.

November 16, 2017
·
10 min read
Business

MediWound Reports Third Quarter 2017 Financial Results

Total revenues for the third quarter of 2017 were $0.74 million, a 43% increase from $0.52 million in the third quarter of 2016.

November 16, 2017
·
16 min read
Orphazyme A/S: Major Shareholder Announcement - Nov. 16, 2017

The company has received the following notifications pursuant to section 29 of the Danish Securities Trading Act regarding the existing major shareholders’ direct and indirect respective holdings of shares in Orphazyme.

November 16, 2017
·
9 min read